IFP Advisors’s Maravai LifeSciences MRVI Stock Holding History

IFP Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	–	–	4089
2024 Q4	–	Hold	0	–	–	–	3316
2024 Q1	–	Sell	-90	Closed	-$590	–	3203
2023 Q4	$590	Sell	90 -395	-81%	-$2.55K	﹤0.01%	2862
2023 Q3	$4.85K	Buy	485 +143	+42%	+$1.57K	﹤0.01%	2512
2023 Q2	$4.25K	Buy	342 +174	+104%	+$2.35K	﹤0.01%	2596
2023 Q1	$5.01K	Sell	168 -612	-78%	-$8.79K	﹤0.01%	2564
2022 Q4	$23K	Buy	780 +540	+225%	+$8.5K	﹤0.01%	2785
2022 Q3	$9K	Buy	240 +131	+120%	+$3.29K	﹤0.01%	3721
2022 Q2	$7K	Hold	109	–	–	﹤0.01%	3609
2022 Q1	$7K	Buy	+109	New	+$3.65K	﹤0.01%	3608
2021 Q4	–	Sell	-200	Closed	-$10K	–	3440
2021 Q3	$10K	Buy	+200	New	+$9.76K	﹤0.01%	2282
2021 Q2	–	Sell	-50	Closed	-$1.94K	–	3156
2021 Q1	$2K	Buy	+50	New	+$1.66K	﹤0.01%	2690

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFP Advisors's MRVI Position: Q1 2025 in Review

IFP Advisors held its Maravai LifeSciences (MRVI) position steady in Q1 2025 at 0 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #4089.

IFP Advisors first reported a position in MRVI in Q1 2021 and has held it in 10 quarters since. The position peaked at $23K in Q4 2022. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

IFP Advisors held 0 shares of Maravai LifeSciences worth $35 as of Q1 2025.
IFP Advisors left its Maravai LifeSciences share count unchanged in Q1 2025.
Maravai LifeSciences made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #4089 holding.
IFP Advisors first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 10 quarters since.
IFP Advisors's Maravai LifeSciences position peaked at $23K in Q4 2022.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.